Financial Statements · Financial Reporting
Asper Biogene OÜ
Official identifier 14265334Record date 31 Dec 2024
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2024
- Period start
- 1 Jan 2024
- Submitted date
- 30 Jun 2025
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 391,956 |
| Balance sheet | Cash and cash equivalents | 64,604 |
| Balance sheet | Current assets | 121,827 |
| Balance sheet | Current liabilities | 90,228 |
| Balance sheet | Equity | 280,450 |
| Balance sheet | Share capital at nominal value | 2,500 |
| Balance sheet | Non-current assets | 270,129 |
| Balance sheet | Non-current liabilities | 21,278 |
| Balance sheet | Retained earnings (loss) from previous periods | 344,068 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -101,208 |
| Income statement scheme 1 | Labour costs | -235,642 |
| Income statement scheme 1 | Revenue | 649,888 |
| Income statement scheme 1 | Annual period profit / loss | -66,368 |
| Income statement scheme 1 | Operating profit (loss) | -62,756 |
| Income statement scheme 1 | Profit (loss) before income tax | -66,368 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 344,068 |
| Note: Labour costs | Employees | 9 |
| Note: Labour costs | Labour costs | 212,485 |
Linked company
Company: Asper Biogene OÜ